老年局部区域性头颈癌患者的管理
本文综述老年局部区域性头颈癌管理的现有证据,指出该人群治疗耐受性降低、合并症多且药代与药效动力学改变,高水平证据稀缺;高龄本身并非治愈性治疗禁忌,评估预期寿命、功能状态与认知衰退应纳入决策,并提出实用治疗流程。
要点
- 高龄本身不构成治愈性治疗的禁忌,但需评估预期寿命、功能状态与认知衰退。
- 老年头颈癌高水平证据稀缺,机器人手术、动态调强放疗、免疫治疗与降阶梯试验或可改善耐受性。
- 作者提出实用治疗流程以协助临床管理老年局部区域性头颈癌患者。
核心结论
- 高龄本身不构成治愈性治疗的禁忌,预期寿命、功能状态受损与认知衰退等年龄相关因素应纳入管理决策。
研究设计与样本
- 本文为综述,汇总老年局部区域性头颈癌管理的现有证据并提出实用治疗流程。
主要发现
- 老年头颈癌管理面临治疗耐受性降低、多重合并症及药代与药效动力学改变等挑战,且高水平证据稀缺。
- 机器人手术、动态调强放疗、免疫治疗与降阶梯试验等进展或可改善该人群的治疗耐受性。
临床怎么用
- 作者提出实用治疗流程供临床医生管理老年局部区域性头颈癌患者时参考。
局限性
- 原文指出针对该患者群体管理的高水平证据稀缺。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Head and neck cancer in elderly patients represents a major health burden because its management provides unique and complex challenges for multidisciplinary teams, such as reduced treatment tolerance, multiple comorbidities, and altered pharmacokinetics and pharmacodynamics. Despite the prominent challenges involved, high-level evidence for the management of this group of patients is scarce. Substantial advances in treatment, such as robotic surgery, dynamic intensity-modulated radiation therapy, immunotherapy, and de-escalation trials, might allow for improved treatment tolerance in this patient population. Advanced age alone does not appear to be a contraindication to curative treatment. Evaluation of age-specific factors such as life expectancy, impaired functional status, and cognitive decline warrant consideration as part of the management decision process. In this Review, we provide an update of the available evidence on the management of locoregionally confined head and neck cancer in elderly patients and propose a practical treatment algorithm for clinicians to help manage this patient population.
引用
- Porceddu SV, Haddad RI. Management of elderly patients with locoregionally confined head and neck cancer. Lancet Oncol. 2017. PMID: 28456589. doi:10.1016/S1470-2045(17)30229-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。